Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2008
10/02/2008WO2008098115A3 Optimized igf-1r antibodies and methods of using the same
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008094484A3 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors
10/02/2008WO2008093075A3 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
10/02/2008WO2008091798A3 Optimized ca9 antibodies and methods of using the same
10/02/2008WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
10/02/2008WO2008080015A3 Compounds and methods for kinase modulation, and indications therefor
10/02/2008WO2008079873A3 Thiazolyl compounds useful as kinase inhibitors
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008075048A3 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments
10/02/2008WO2008071456A3 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/02/2008WO2008070009A3 Treating solid tumors and monocytic leukemia using topoisomerase inhibitors in liposomes
10/02/2008WO2008064866A8 Treatment for multiple myeloma
10/02/2008WO2008057604A9 Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
10/02/2008WO2008051826A3 Purines as pkc-theta inhibitors
10/02/2008WO2008049902A3 Macrocyclic quinazoline derivatives as vegfr3 inhibitors
10/02/2008WO2008026125A3 Anti cancer use of caffeic acid and derivatives
10/02/2008WO2008001101A3 Pharmaceutical combinations
10/02/2008WO2007093806A8 Dissolution aids for oral peptide delivery comprising a biguanide
10/02/2008US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders
10/02/2008US20080242726 may contain both cis-clomiphene and trans-clomiphene, and the ratio of trans-clomiphene and cis-clomiphene may be greater than 71/29; extended release
10/02/2008US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders
10/02/2008US20080242709 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
10/02/2008US20080242707 Using 4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-2-pyridinecarboxylic acid methyl amide
10/02/2008US20080242704 selectively modulate, regulate, and/or inhibit signal transduction; potent and selective c-kit, bcr-abl and Fit-3 inhibitors; diseases like cell proliferation, metabolic, allergic, cancers, degenerative, autoimmune disorders; 4-{2-[5-(Benzothiazol-2-ylammo)-2-methyl-phenylamino]-oxazol-5-yl}-benzonitrile
10/02/2008US20080242702 Paclitaxel enhancer compound
10/02/2008US20080242694 inhibition of a kinase pathway for the treatment of cancer, inflammatory, immunological and metabolic conditions; agents may target two or more kinases of the same/different family; [2-AMINO-1-(2-PHENYLETHYL)ETHYL](5-(6-ISOQUINOLYL)(1,3,4-THIADIAZOL-2-YL))AMINE
10/02/2008US20080242692 Synthesis of Indenoisoquinoliniums and Methods of Use
10/02/2008US20080242691 Aqueous Solution Preparation Containing Camptothecins
10/02/2008US20080242686 Pharmaceutical compositions of lavendustin
10/02/2008US20080242685 Chemical Compounds
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242675 Prevent transplant rejection
10/02/2008US20080242667 e.g. N-(4-{4-[2-({3-[2-(4-Morpholinyl)ethyl]phenyl}amino)-4-pyrimidinyl]-1H-pyrazol-3-yl}phenyl)benzamide; serine/threonine kinase inhibitor; anticarcinogenic, antitumor agent
10/02/2008US20080242665 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticarcinogenic agent;
10/02/2008US20080242664 Dna-pk inhibitors
10/02/2008US20080242663 [3-[[2-[(3,5-dimorpholin-4-ylphenyl)amino]pyrimidin-4-yl]-methyl-amino]-4-methyl-phenyl]methanol; protein tyrosine kinase EphB4 inhibitor; inhibit DNA synthesis; antiproliferative, antitumor agent
10/02/2008US20080242658 Inhibitors of Iap
10/02/2008US20080242655 Aza-indolyl compounds and methods of use
10/02/2008US20080242654 Novel compounds as cannabinoid receptor ligands
10/02/2008US20080242652 Indole derivatives and their metal conjugates and uses thereof
10/02/2008US20080242648 COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
10/02/2008US20080242638 Induction of differential stress resistance and uses thereof
10/02/2008US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders
10/02/2008US20080242628 In vivo
10/02/2008US20080242620 Stimulation T-cell transformation; cell proliferation disorders; anticancer agents; antiscarcoma; mixture of tripeptide and carrier ; nutrient
10/02/2008US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders
10/02/2008US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain
10/02/2008US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent
10/02/2008US20080242603 Interleukins; genetic engineering; vectors and host cells; anticancer agents; immunology diseases; infections; antiischemic agents; antitumor agents
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080242598 Short chain peptide; conformation scaffolds; diecting amino acids into positions; controlling apoptosis; tumor suppression; alcoholism; drug abuse; antiepileptic agents
10/02/2008US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241283 Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same
10/02/2008US20080241282 Alcohol extractable fraction of Sorghum bicolor grain; reduce lipopolysaccharide induced nuclear factor-kappa B activation; chronic or transitory inflammatory disease, anti-cancer, anti-diabetic activity in mammal or avian
10/02/2008US20080241277 Herbal formulation for the treatment of bone fractures and osseous defects
10/02/2008US20080241274 Indibulin therapy
10/02/2008US20080241262 Nanoshells and Discrete Polymer-Coated Nanoshells, Methods For Making and Using Same
10/02/2008US20080241256 Targeted active agent delivery system based on calcium phosphate nanoparticles
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241171 Stem Cell Populations and Methods of Use
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241163 Tweak binding antibodies
10/02/2008US20080241161 Liposome encapsulated antitumor immunoglobulin fusion for use in treatment of breast cell proliferative disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241155 Death domain containing receptor 4
10/02/2008US20080241148 Treatment with anti-vegf antibodies
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241128 Antibodies; anticancer agents; autoimmune disorders
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241123 self-assembly; made from one or more species selected from the group of carbon, silicon, a noble metal, silicon dioxide and titanium dioxide; for treatment of tumors or targeted drug delivery when a magnetic field or near-IR radiation is applied
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008US20080241077 Benzoylguanidine salt and hydrates thereof
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241066 Anti-PRL-3 antibodies and methods of use thereof
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008US20080241062 Cancerous disease modifying antibodies
10/02/2008US20080241061 diagnostic drug containing lecithin, n-{w-[4-(p-maleimidophenyl)butanoyl]amino}polyethylene glycol]1,2-distearoyl-sn-glycerol-3-phsphoethanolamine covalently coupled to alpha-beta-integrin peptidomimetic antagonist chelated with Tc isotopes; to identify location of neovasculature associated with a tumor
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2682661A1 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
10/02/2008CA2682059A1 Human anti cd166 antibody binding human tumor cells
10/02/2008CA2682027A1 Modulation of tumor microenvironment
10/02/2008CA2681917A1 Methods and compositions for treating prostate cancer
10/02/2008CA2681827A1 Methods of treating cancer by administering human il-18 combinations
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 2211